معرفی
Professor Alexander Baldacchino is a Professor of Medicine, Psychiatry and Addictions at the University of St Andrews School of Medicine. He is also a retired Consultant Psychiatrist with NHS Fife and holds leadership roles in global addiction medicine organizations such as Chair of the World Psychiatric Association (WPA) Addiction Psychiatry Section and Immediate Past President of the International Society of Addiction Medicine (ISAM). His research focuses on improving outcomes for individuals with substance misuse problems through informatic systems, clinical outcome analysis, and neuroimaging.
Prof Baldacchino holds academic qualifications including a PhD in Medicine from the University of Dundee (2012) and an MD from the University of Malta (1987). He has held positions at St George's Hospital Medical School (London) and Ninewells Hospital Medical School (Dundee). His clinical expertise spans general psychiatry, addiction medicine, and dual diagnosis management.
His research interests include understanding comorbid conditions arising from chronic substance abuse, particularly opioids and alcohol. He has pioneered studies on telemedicine applications, digital health interventions, and opioid overdose prevention technologies. Notable projects include the ORION e-Health tool for overdose risk assessment and the European-funded CAMILLE Project empowering children of mentally ill parents.
Prof Baldacchino has authored over 170 publications and secured significant research grants, including EU projects totaling millions of Euros. His work addresses global challenges such as medication-assisted treatment accessibility, digital exclusion among homeless populations, and opioid prescribing practices. He has received prestigious awards including Fellowships from the Royal College of Physicians and Psychiatrists.
Current initiatives focus on advancing addiction psychiatry through global collaborations, policy advocacy, and mentorship of early-career professionals. His career spans 40 years of clinical care and academic contributions, aiming to improve quality of life for patients and families affected by substance use disorders.
